Sleep Apnea Implants Market Worth $803.26 Million by 2030 - Exclusive Report by The Insight Partners
18 oct. 2023 08h18 HE
|
The Insight Partners
Pune, India, Oct. 18, 2023 (GLOBE NEWSWIRE) -- North America accounted for the largest share of the global sleep apnea implants market in 2022. The North America sleep apnea implants market has...
Incannex engages Fortrea to Manage its FDA IND Opening Phase 2/3 Clinical Trial Investigating IHL-42X for Treatment of Obstructive Sleep Apnoea
18 juil. 2023 07h40 HE
|
Incannex Healthcare
Highlights: Incannex has engaged Fortrea as the contract research organisation (‘CRO’) to manage the IND opening Phase 2/3 clinical trial investigating IHL-42X for treatment of OSA.The Phase 2/3...
PAP Devices Market to Be Worth $6.63 Billion by 2030 — Exclusive Report by Meticulous Research®
28 juin 2023 09h00 HE
|
Meticulous Market Research Pvt. Ltd.
Redding, California, June 28, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, ‘PAP Devices Market by Type [CPAP, BiPAP, APAP, Accessories (Masks, Headgear)], Disease...
Sleep Apnea Devices Market Size is projected to reach USD 6.79 billion by 2030, growing at a CAGR of 6.30%: Straits Research
15 juin 2023 10h10 HE
|
Straits Research
New York, United States, June 15, 2023 (GLOBE NEWSWIRE) -- The abnormal breathing pattern that a person experiences while they are asleep is a sign of the sleeping disorder known as sleep apnea....
PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP
08 juin 2023 09h00 HE
|
ResMed Inc.
The studies also showed 18-40% lower costs incurred from ER visits and hospitalizations after 1 year for PAP-adherent OSA patients with diastolic and systolic heart failure, respectivelyA third study...
3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023
25 mai 2023 09h00 HE
|
ResMed Inc.
France’s Jean-Louis Pépin and Germany’s Holger Woehrle presented studies in which treating OSA with CPAP lowered all-cause mortality for PAP vs. non-PAP users with OSAGermany’s Michael Arzt presented...
UAE Sleep Apnea Devices Market Report 2023: Rise in Clinical Awareness About Sleep Apnea Fuels Growth
02 mars 2023 06h18 HE
|
Research and Markets
Dublin, March 02, 2023 (GLOBE NEWSWIRE) -- The "UAE Sleep Apnea Devices Market, By Type (Therapeutic v/s Diagnostic), By Indication (Obstructive Sleep Apnea v/s Central Sleep Apnea), By End User...
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2023
26 janv. 2023 16h05 HE
|
ResMed Inc.
Year-over-year revenue grows 16%, operating profit up 13%, non-GAAP operating profit up 14% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today...
ResMed Appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to Become Chair Emeritus
26 janv. 2023 16h05 HE
|
ResMed Inc.
SAN DIEGO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced ResMed’s board of directors has appointed chief executive officer Michael (“Mick”) Farrell as chair of the...
RemSleep Holdings Inc. Issues Letter to Shareholders
06 janv. 2023 14h09 HE
|
RemSleep Holdings, Inc.
Tampa, FL, Jan. 06, 2023 (GLOBE NEWSWIRE) -- RemSleep Holdings Inc. (OTCQB: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep...